If reports prove accurate, tomorrow may mark the most significant shift in federal drug policy in 55 years. Multiple administration sources are signaling that President Trump is poised to follow through on what has long been teased: rescheduling cannabis from Schedule I to Schedule III under the Controlled Substances Act.
Trending
- More Alabama Medical Marijuana Dispensaries Are Set To Open This Week, Officials Announce
- Marijuana Businesses Face Tax Uncertainty While Awaiting Federal Rescheduling Guidance
- Hemp Imports Would Face New Tariffs And Testing Requirements Under Congressional Bill
- Alcohol Lobbyists Encouraged Law Enforcement Officials To Push For Federal Hemp Crackdown, Report Says
- DEA Officially Grants Federal Registration And Protections To More Than 900 Medical Marijuana Dispensaries
- DEA Refuses To Approve Marijuana Businesses In States That Allow Dual Medical And Recreational Licensing
- Massachusetts May Legalize Medical Cannabis Access for Out-of-State Patients
- DEA Warns Medical Marijuana Businesses To Only Obtain Products From Federally Registered Companies
